Purinergic P2X7 receptor antagonists: Chemistry and fundamentals of biological screening

被引：11
|
作者：
Gunosewoyo, Hendra [1 ,2 ]
Coster, Mark J. [3 ]
Bennett, Maxwell R. [2 ]
Kassiou, Michael [1 ,2 ,4 ]
机构：
[1] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia
[2] Brain & Mind Res Inst, Sydney, NSW 2050, Australia
[3] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia
[4] Univ Sydney, Discipline Med Radiat Sci, Sydney, NSW 2006, Australia
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2009年 / 17卷 / 14期
关键词：
P2X7; antagonists; Cytokine release; Rational drug design; LL-37; IN-VITRO ACTIVITY; INTERLEUKIN-1-BETA RELEASE; POLYMYXIN-B; POTENT; DISCOVERY; PEPTIDE; LL-37; PAIN; TAIL;
D O I：
10.1016/j.bmc.2009.05.083
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The purinergic P2X(7) receptor is a unique member of the ATP-gated P2X family. This receptor has been implicated in numerous diseases and many structurally diverse ligands have been discovered via high throughput screening. This perspective will attempt to highlight some of the most recent key findings in both the biology and chemistry. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码：4861 / 4865
页数：5
相关论文
共 50 条
  • [31] Novel P2X7 receptor antagonists ease the pain
    King, B. F.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 151 (05) : 565 - 567
  • [32] Cubyl amides:: Novel P2X7 receptor antagonists
    Gunosewoyo, Hendra
    Guo, Jun Liu
    Bennett, Maxwell R.
    Coster, Mark J.
    Kassiou, Michael
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (13) : 3720 - 3723
  • [33] P2X7 purinergic receptor: A potential target in heart diseases (Review)
    Dayel, Anfal Bin F.
    Alonazi, Asma S.
    Alshammari, Tahani K.
    Alrasheed, Nouf M.
    MOLECULAR MEDICINE REPORTS, 2023, 27 (03)
  • [34] The purinergic receptor P2X7 is a crucial inducer of inflammation in contact hypersensitivity
    Weber, F. C.
    Esser, P. R.
    Mueller, T.
    Ganesan, J.
    Pellegatti, P.
    Simon, M. M.
    Zeiser, R.
    Idzko, M.
    Jakob, T.
    Martin, S. F.
    EXPERIMENTAL DERMATOLOGY, 2011, 20 (02) : 178 - 179
  • [35] The P2X7 purinergic receptor on bovine macrophages mediates mycobacterial death
    Smith, RA
    Alvarez, AJ
    Estes, DM
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2001, 78 (3-4) : 249 - 262
  • [36] Involvement of the P2X7 Purinergic Receptor in Inflammation: An Update of Antagonists Series Since 2009 and their Promising Therapeutic Potential
    Baudelet, Davy
    Lipka, Emmanuelle
    Millet, Regis
    Ghinet, Alina
    CURRENT MEDICINAL CHEMISTRY, 2015, 22 (06) : 713 - 729
  • [37] The purinergic receptor P2X7, a new therapeutic target in Alzheimer disease
    Martin, Elodie
    Kanellopoulos, Jean
    Fontaine, Bertrand
    Delatour, Benoit
    Delarasse, Cecile
    M S-MEDECINE SCIENCES, 2019, 35 (02): : 97 - 99
  • [38] The P2X7 purinergic receptor: An emerging therapeutic target in cardiovascular diseases
    Chen, Zhe
    He, Lu
    Li, Lanfang
    Chen, Linxi
    CLINICA CHIMICA ACTA, 2018, 479 : 196 - 207
  • [39] Recent Advances in the Development of Antidepressants Targeting the Purinergic P2X7 Receptor
    Lee, Shinyoung
    Ha, Hyunsoo
    Jang, Jaebong
    Byun, Youngjoo
    CURRENT MEDICINAL CHEMISTRY, 2023, 30 (02) : 164 - 177
  • [40] The P2X7 purinergic receptor: a potential therapeutic target for lung cancer
    Li, Qianqian
    Zhu, Xiaodi
    Song, Wei
    Peng, Xiaoxiang
    Zhao, Ronglan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (11) : 2731 - 2741
12345